Calls Horizon Europe Cluster Health
We are excited to announce that new calls of the Horizon Europe Cluster Health with a budget of €67 million, are now open and will expire on April 21, 2022. You can find more information here.
Open access policy monitoring report of Horizon 2020 is out!
The report examines, monitors, and quantifies compliance with the open access requirements of Horizon 2020 for both publications and research data. The European Commission’s leadership in the Open Science policy has paid off based on the key findings that indicate a steadily increase over the years and an average success rate of 83% open access [...]
6th European Conference on Clinical Research
The 6th European Conference on Clinical Research organized by the European CRO Federation (EUCROF) took place on 07 & 08 February 2022 in Madrid (Spain) as a hybrid conference. The conference counted with a total of 271 participants, 174 present in Madrid, and 97 joining on-line. The content of the scientific programme was based on [...]
Pharmaceutics special issue dedicated to EPTRI
The Pharmaceutics journal dedicated a special issue, the “Scientific Highlights in the First European Paediatric Translational Research Infrastructure (EPTRI) Open Meeting” to highlight its important event. This special issue is addressed to all researchers and partners involved in the development of paediatric medicines and it presented several research papers touching different topics, such as: [...]
2nd International Conference on Rare Diseases, Tuesday 1st and Wednesday 2nd of March 2022, online
“The Balancing Act between Equity and Sustainability”. This year’s conference recognizes the need to promote and protect the human rights of all persons, including the estimated 300 million persons living with a rare disease worldwide, many of whom are children, by ensuring equal opportunities to achieve their optimal potential development and to participate in society [...]
ICH-CGP training course
CVBF is pleased to present its e-learning “ICH-Good Clinical Practice (GCP) Training Course”, aimed at providing a guide for all professionals involved in clinical research and clinical trials that need to acquire GCP knowledge. The e-learning ICH-GCP training course is based on the international E6 ICH Good Clinical Practice (R2), revised in 2016, and meets [...]
2022 starts with three new scientific publications
CVBF is excited to announce that three new research articles counting with the participation of experts from our consortium, were recently published. “Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018” analysed and described post-authorization studies (PAS) in the European PAS (EU PAS) register. There is [...]
CVBF is now a member of the European Open Science Cloud
We are happy to announce that CVBF is now a member of the (EOSC). This will ensure compliance with new Open Science policy in the EU and facilitate the exchange of information among researchers and funders. EOSC is recognised by the Council of the European Union as the pilot action to deepen the new European [...]
EJP RD Training on strategies to foster solutions of undiagnosed rare disease cases
As part of the training activities proposed by EJP RD, an online training course on “Training on strategies to foster solutions of undiagnosed rare disease cases” is being organised by Istituto Superiore di Sanità (ISS) in close collaboration with EJP RD partners. The online event will take place over three days from on April 11th – 13th. Through the presentation of sample use cases that [...]
Task Force on Disregarded Rare Diseases (Pluto Project)
The Therapies Scientific Committee (TSC) of the International Rare Diseases Research Consortium (IRDiRC) is establishing a Task Force to characterize specific commonalities amongst a large group of “disregarded” rare diseases, with the potential secondary aims to identify removable roadblocks that may foster future research and development. The TSC is specifically looking for members to populate the Task Force with the below expertise in one [...]